Professor, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, and Professor, Department of Pediatrics at Penn State University
Garadacimab Shuts Down Contact Pathway to Treat HAE: Timothy Craig, DO
With the approval of the FDA, garadacimab can help patients with hereditary angioedema (HAE) prevent attacks by shutting down the contact pathway.